February 27, 2024

Identification of P21 (CDKN1A) Activated Kinase 4 as a Susceptibility Gene for Familial Non-Medullary Thyroid Carcinoma

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Familial non-medullary thyroid carcinoma (FNMTC) is a genetically predisposed disease with unclear genetic mechanisms. This makes research on susceptibility genes important for the diagnosis and treatment options.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Jiang et al. (Tue,) studied this question.

synapsesocial.com/papers/68e7757db6db6435876ea749 https://doi.org/https://doi.org/10.1089/thy.2023.0564

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys2022 · 20 citations
2Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis2021 · 262 citations
3BROX haploinsufficiency in familial nonmedullary thyroid cancer2020 · 11 citations
4Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: A SNP array-based linkage analysis of 38 families2009 · 64 citations
5Clinical Features and Genetic Predisposition to Hereditary Nonmedullary Thyroid Cancer2009 · 120 citations

Preguntar a la IA

Me gusta

Guardar